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a  b  s  t  r  a  c  t
Animal  African  trypanosomoses  (AAT)  are  caused  by  ﬂagellated  protozoa  of the  Try-
panosoma  genus  and contribute  to  considerable  losses  in  animal  production  in  Africa,  Latin
America  and  South  East  Asia.  Trypanosoma  congolense  is considered  the  economically  most
important  species.  Drug  resistant  T. congolense  strains  present  a threat  to  the  control  of
AAT and have  triggered  research  into  discovery  of novel  trypanocides.  In vivo  assessment
of  trypanocidal  efﬁcacy  relies  on  monitoring  of  treated  animals  with  microscopic  parasite
detection  methods.  Since  these  methods  have  poor  sensitivity,  follow-up  for  up to  100  days
after treatment  is  recommended  to  increase  the chance  of  detecting  recurrent  parasitaemia
waves.  Molecular  techniques  are  more  amendable  to  high  throughput  processing  and  are
generally  more  sensitive  than  microscopic  detection,  thus  bearing  the  potential  of short-
ening  the  100-day  follow  up  period.  The  study  presents  a “Touchdown”  PCR  targeting  the
internal  transcribed  spacer  1  of  the  ribosomal  DNA  (ITS1  TD  PCR)  that  enables  detection
and  discrimination  of  different  Trypanosoma  taxa  in  a single  run  due  to variations  in PCR
product  sizes.  The  assay  achieves  analytical  sensitivity  of 10  parasites  per  ml  of  blood  for
detection  of T. congolense  savannah  type  and  T. brucei,  and  100  parasites  per  ml  of blood  for
detection  of  T. vivax  in  infected  mouse  blood.  The  ITS1  TD  PCR was  evaluated  on  cattle  exper-
imentally  infected  with  T.  congolense  during  an  investigational  new  veterinary  trypanocide
drug  efﬁcacy  study.  ITS1  TD  PCR  demonstrated  comparable  performance  to  microscopy  in
verifying  trypanocide  treatment  success,  in  which  parasite  DNA  became  undetectable  in
cured  animals  within  two  days  post-treatment.  ITS1  TD  PCR  detected  parasite  recrudes-
cence  three  days  earlier  than  microscopy  and  had  a higher  positivity  rate  than  microscopy
(84.85%  versus  57.58%)  in 66  specimens  of  relapsing  animals  collected  after  treatments.
Therefore,  ITS1  TD  PCR  provides  a useful  tool  in  assessment  of drug  efﬁcacy  against  T.  con-
golense  infection  in  cattle.  As  the  assay  bears  the  potential  for detection  of  mixed  infections,
it  may  be  applicable  for  d
T. congolense  against  othe
equiperdum.
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. Introduction
Animal African trypanosomoses (AAT) are infectious
iseases of livestock that kill approximately 3 million cattle
ach year, with a further 50 million at risk of the dis-
ase (FAO, 2003). AAT contribute to poor meat and milk
roduction, poor growth of young stock and reduction in
ertility (Shaw et al., 2014). The causative agents of AAT
re ﬂagellated protozoa of the Trypanosoma genus. Try-
anosoma congolense,  T. vivax and T. brucei cause wasting
isease nagana, mainly in ruminants, and are transmitted
y tsetse ﬂies in sub-Saharan Africa. T. vivax also occurs
n Latin America where it is transmitted by other blood
ucking ﬂies. T. evansi causes surra in camels, horses and
uminants and occurs in Northern and Eastern Africa, Latin
merica, South East Asia and sporadically in Southern
urope. T. equiperdum causes dourine that is a sexually
ransmitted ubiquitous disease of equines (Hoare, 1972). T.
ongolense is considered the economically most important
pecies that induces severe pathology in cattle, includ-
ng anaemia, weakness and immune depression (Sharpe
t al., 1982; Mwangi et al., 1990). Emergence of drug resis-
ance presents a threat to the control of trypanosomosis
nd has triggered research on new compounds against
frican trypanosomes (Chitanga et al., 2011; Mungube
t al., 2012).
The UK government’s Department for International
evelopment (DFID) has funded an AAT drug, diagnos-
ics and vaccine discovery programme administered by
he Global Alliance for Livestock Veterinary Medicines
GALVmed) a not-for-proﬁt company based in Edinburgh,
cotland. A key effort in this programme is to discover and
evelop new trypanocide treatments to overcome current
ssues of toxicity and resistance which are inherent to the
xisting trypanocides (homidium, isometamidium, and
iminazene) that have been used in Africa for more than 50
ears. Given the signiﬁcant resources and effort invested
n human African trypanosomosis (HAT) drug discovery by
roups such as the Drugs for Neglected Diseases initiative
DNDi)  the opportunity exists to explore candidate try-
anocidal compounds for efﬁcacy against AAT. GALVmed
as deﬁned trypanocide compound progression criteria
nd Target Product Proﬁle (TPP) criteria for AAT try-
anocides to aid in their development and is progressing
uitable candidates into development for therapeutic and
rophylactic treatments of AAT (http://www.galvmed.
rg/2012/04/trypanosomosis/). Development includes
ssessing the efﬁcacy of suitable candidate trypanocide
ompounds against drug-resistant T. congolense and T.
ivax isolates in the target species, namely cattle.
Trypanocide efﬁcacy studies determine parasite clear-
nce in cattle following treatment. These studies are how-
ver hampered by the generally low analytical sensitivity
f microscopical trypanosome detection methods resulting
n a recommended 100 days of post treatment follow-up
ith frequent examination of the blood (Eisler et al., 2001).
 commonly used microscopic test and considered “gold
tandard” is the haematocrit centrifugation technique
HCT, (Woo, 1970)) with a generally accepted detection
imit of about 500 parasites per ml  of blood. As HCT
etects living trypanosomes, the test should be performedogy 202 (2014) 164–170 165
quickly after specimen collection. To overcome the limi-
tations of microscopical analysis, molecular methods have
been introduced in compound efﬁcacy studies against AAT.
For example, a PCR targeting a Trypanosomatidae-speciﬁc
18S rDNA was able to detect T. evansi parasites with a
median of 10 days earlier than HCT in goats that relapsed
more than 100 days after treatment (Gillingwater et al.,
2011). Another PCR, targeting multi-copy internal tran-
scribed spacer 1 (ITS1) rDNA sequences, may  serve the
same purpose but with the advantage that it is able to iden-
tify the trypanosome species or subgenus by the amplicon
length polymorphism (McLaughlin et al., 1996).
ITS1, situated between the conserved 5.8S and 18S
genes encoding the ribosomal RNA subunits, occurs
in approximately 100–200 copies per genome of a
trypanosome. Due to variation in sizes of ITS1 amongst dif-
ferent Trypanosoma taxa, discrimination between species
or subgenus is possible in a single run (McLaughlin et al.,
1996; Desquesnes et al., 2001). ITS1 or nested ITS1/ITS2-
based PCR assays have proven useful in trypanosomosis
diagnosis and in epidemiological studies (Njiru et al., 2005;
Cox et al., 2005; Thumbi et al., 2008; de Clare Bronsvoort
et al., 2010; Fikru et al., 2012). The authors claimed that
the universal ITS-based PCR assays reduce cost and time of
running several species-speciﬁc assays, especially in large-
scale studies. ITS1 PCR that was used in an epidemiological
survey in Ethiopia revealed a ﬁve-fold higher detection rate
for T. vivax compared to HCT (Fikru et al., 2012). How-
ever, evaluation of the assay as a test of cure has not
been reported and these ITS1 PCR assays are prone to
non-speciﬁc ampliﬁcation, particularly with bovine blood
(unpublished observations). Therefore, the assay presented
in this study was further reﬁned for optimal performance.
“Touchdown” PCR approach, which employs more strin-
gent primer-template hybridisation temperatures, was
introduced to enhance assay speciﬁcity. In Touchdown PCR,
the annealing temperature during the ﬁrst PCR cycles is
well above the predicted optimal annealing temperature of
the primers thus favouring the ampliﬁcation of the speciﬁc
target sequence. In the following PCR cycles, the anneal-
ing temperature is gradually lowered to more permissive
temperatures. By maintaining the same high number of
ampliﬁcation cycles as in a classical PCR, the sensitivity is
not compromised (Don et al., 1991; Korbie and Mattick,
2008).
The objectives of this study were (1) to develop an ITS1
“Touchdown” PCR for multi-taxon detection of the Try-
panosoma genus and (2) to evaluate the performance of this
ITS1 TD PCR as test of cure in an efﬁcacy study designed to
evaluate novel trypanocidal compounds in cattle infected
with T. congolense.
2. Materials and methods
2.1. Ethical clearanceAnimal studies at the Institute of Tropical Medicine
(ITM, Antwerp, Belgium) received ethical clearance from
the Veterinary Ethics Committee at ITM (BMW 2012-1 and
BMW  2013-7).
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Animal studies at ClinVet (Bloemfontein, South Africa)
received ethical approval from the ClinVet Animal Ethics
Committee (CAEC) authorising the research facility to
conduct three studies CV12/884; CV 12/928; CV12/885.
Animals were housed and cared for in accordance with
national and international legislation, and local animal reg-
ulatory requirements.
2.2. Parasite strains
The following T. congolense strains were used for infec-
tion of cattle: KONT 2/133, KONT 2/151 (Mamoudou et al.,
2008), Maputo 31J, Maputo 02J (unpublished).
For test development, the following strains were used
for infection of mice: T. congolense YOBO 2038, TRT 17,
Lion 209 (Delespaux et al., 2008), STIB 212 (Nantulya
et al., 1980); T. vivax ILRAD 700, IL 1392 (Leeﬂang et al.,
1976); T. brucei brucei AnTat 1.1, T. b. gambiense AnTat 9.1
(Van Meirvenne et al., 1975), T. evansi RoTat 1.2 (Bajyana
Songa and Hamers, 1988), T. b. rhodesiense ETat 1.2 (Van
Meirvenne et al., 1976), T. equiperdum OVI (Barrowman,
1976) and T. theileri Melsele (Verloo et al., 2000).
2.3. Trypanocide efﬁcacy studies
The trypanocide efﬁcacy studies were carried out
at ClinVet, Bloemfontein, South Africa. All cattle were
Trypanosoma-susceptible, castrated males and females
of the Friesian–Holstein breed. The animals were at
least four months of age and had been weaned for at
least two months. Animals originated from a tsetse and
Trypanosoma-free area, were negative for trypanosomosis
(PCR-RFLP assay for T. congolense and T. vivax, (Geysen et al.,
2003)) and negative for T. theileri on blood smear performed
at ClinVet International (Pty) Ltd. Animals were identiﬁed
by ear tags, were weighed at regular intervals through-
out the study and were given a standard diet of hay and
a commercial, supplemented, concentrate feed (without
added antimicrobial agents) sufﬁcient to support growth
rates of approximately 700 g/day in healthy growing cat-
tle. Animals were housed in a fully enclosed, purpose-built,
ﬂy-proof facility for cattle containing 36 ﬂexible pens.
For this evaluation, blood samples from a total of
57 animals across 3 studies were used. Twelve animals
were non-infected and 45 animals were infected with a
single T. congolense strain per animal. Fresh heparinised
blood (0.1 mL)  from an infected donor animal contain-
ing the pathogen (infective dose of approximately 100,000
parasites as determined by counting using the Uriglass dis-
posable counting chamber (Menarini Diagnostics, Austria))
was administered by slow intravenous injection into the
jugular vein of recipient calves within 15 min  after col-
lection. For assessment of trypanocide efﬁcacy in study
CV12/885, two groups of six animals each, namely groups
A and B (i.e. 12 out of the 45 infected cattle) were infected
with the drug resistant strain KONT 2/133 and each group
was given a different trypanocide 9 days after infection
when obvious parasitaemia and anaemia were present
together with variable clinical signs. Day of ﬁrst treatment
administration was designated day 0. Animals were then
monitored for 100 days according to Eisler et al. (2001).logy 202 (2014) 164–170
Animals in group B relapsed and were retreated with
another trypanocide 19 days after the ﬁrst treatment. Ani-
mals in Group A did not relapse after treatment.
From the infected animals, blood for PCR and parasite
detection was collected on either 9 or 5 days pre-infection
(45 trypanosome negative control specimens) and at 14
days post-infection and prior to trypanocide administra-
tion (45 trypanosome positive control specimens). From
the non-infected animals, blood was taken at days cor-
responding with the sampling from the infected animals
(24 trypanosome negative control specimens). These spec-
imens were used for evaluation of the sensitivity and
speciﬁcity of ITS1 TD PCR.
From groups A and B, blood samples for PCR and HCT
were collected after treatment with trypanocides, on 1, 2,
3, 4, 6, 10, 16, 23, 30 and 44 days post-treatment. These
specimens were used for evaluation as a “test of cure”
of ITS1 TD PCR. Blood was  drawn from the jugular vein
into K2-EDTA vacutainer tubes. The blood was  stored at
−80 ◦C for subsequent DNA extraction. For parasite detec-
tion, blood was drawn into heparinised collection tubes,
transferred to 6 heparin-containing capillary tubes and
centrifuged for 6 min  at 13,000 × g. The buffy coat was
examined under a microscope for the presence of living
trypanosomes according to Woo  (1970).
For assessing the speciﬁcity of the PCR primers, non-
infected blood collected on heparin or on Na2-EDTA from
bovine, goat, dog, horse, human and mouse was  used.
2.4. DNA puriﬁcation
Total genomic DNA was extracted from 200 l of blood
using the High Pure PCR Template Puriﬁcation Kit (Roche
Applied Sciences) according to the manufacturer’s instruc-
tions, except that bound DNA was  eluted with 60 l elution
buffer instead of 200 l. Puriﬁed DNA was  stored at −80 ◦C.
Each round of DNA extraction included a negative control
(PCR-grade water) and a positive control (parasite DNA-
spiked blood) alongside the bovine blood specimens. For
determination of the analytical sensitivity, trypanosomes
were grown in mice and parasites were counted in a Uri-
glass cell counting chamber. Since bovine blood was  not
readily available at the ITM in Antwerp, 10-fold serial dilu-
tions of parasites were prepared in 1 ml  volumes of ice-cold
freshly collected naïve human or mouse blood. Two hun-
dred l of the thus prepared blood series were subjected
to DNA puriﬁcation as described above. For assessment of
analytical speciﬁcity, trypanosomes were grown in mice.
Trypanosomes were separated from the blood by anion
exchange chromatography (Lanham and Godfrey, 1970)
and subjected to DNA puriﬁcation with the DNeasy Blood
and Tissue kit (Qiagen) according to the manufacturer’s
instructions.
2.5. ITS1 TD PCR and agarose electrophoresis analysis
ITS1 primers for detection of the Trypanosoma genus
were described in Claes et al. (2007). Primer sequences
are: ITS1-Forward 5′-TGT AGG TGA ACC TGC AGC TGG
ATC, ITS1-Reverse 5′-CCA AGT CAT CCA TCG CGA CAC GTT.
PCR assays were performed in a Biometra T3000 cycler
Parasitology 202 (2014) 164–170 167
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Fig. 1. Ethidium bromide-stained agarose gel electrophoresis of PCR
products generated from genomic DNA of T. b. brucei (Tbb), T. b. gambiense
(Tbg), T. b. rhodesiense (Tbr), T.evansi (Tev), T. equiperdum (Teq), T. vivax
(Tvi), T. congolense Savannah type (Tco) and T. theileri (Tth). M:  100 bp
incremental markers.
Fig. 2. Ethidium bromide-stained agarose gel electrophoresis of ITS1 TD
PCR products of T. congolense Savannah type genomic DNA extracted from
blood. 105, 104, 103, 102, 10, 5: 105 parasites per ml  blood, 104 parasites
per  ml  blood, 103 parasites per ml  blood, 102 parasites per ml blood, 10
known disease status. Speciﬁcity of ITS1 TD PCR was  100%,
which was  in agreement with that of HCT. Sensitivity of
ITS1 TD PCR at 14 days post infection was 100%, and that of
HCT was 97.8%.
Fig. 3. Ethidium bromide-stained agarose gel electrophoresis of ITS1 TD
PCR products of T. vivax gDNA extracted from blood. 105, 104, 103, 102, 10,T. Tran et al. / Veterinary 
Germany). Each reaction contained a ﬁnal volume of 50 l,
ncluding 5 l of template DNA, 200 M of each dNTP
Eurogentec), 0.2 M of each primer (Biolegio), 1 unit of
ot Star Taq Plus DNA polymerase (Qiagen), 1× Coral Load
CR buffer, and 0.1 mg/ml  acetylated bovine serum albu-
in  (Promega). PCR ampliﬁcation was carried out over 40
ycles at the following conditions: initial activation step at
5 ◦C for 5 min; three ampliﬁcation cycles with 94 ◦C for
0 s, 70 ◦C for 30 s, 72 ◦C for 30 s; three cycles with 94 ◦C for
0 s, 69 ◦C for 30 s, 72 ◦C for 30 s; three cycles with 94 ◦C
or 30 s, 68 ◦C for 30 s, 72 ◦C for 30 s; three cycles with 94 ◦C
or 30 s, 67 ◦C for 30 s, 72 ◦C for 30 s; three cycles with 94 ◦C
or 30 s, 66 ◦C for 30 s, 72 ◦C for 30 s; three cycles with 94 ◦C
or 30 s, 65 ◦C for 30 s, 72 ◦C for 30 s; 22 cycles with 94 ◦C
or 30 s, 64 ◦C for 30 s, 72 ◦C for 30 s. A ﬁnal extension step
ccurred at 72 ◦C for 5 min. Each PCR run included a positive
ontrol (0.5 ng parasite DNA) and a no-template negative
ontrol (5 l PCR-grade water).
PCR products were resolved by electrophoresis at
 V/cm in 2% (w/v) agarose gels stained with 0.5 g/ml
thidium bromide, and photographed under ultraviolet
ight.
.6. Vertebrate cytochrome b PCR
On all blood specimens that were negative in the ITS1
D PCR, a PCR for vertebrate cytochrome b was performed
Kocher et al., 1989; Fikru et al., 2012). A positive result with
ertebrate cytochrome b PCR indicates that a negative ITS1
D PCR result of the same specimen is not due to poor DNA
uality or presence of inhibitors.
. Results
.1. Analytical speciﬁcity and sensitivity of ITS1 TD PCR
The ITS1 TD PCR assay conditions were optimised in
rder to obtain maximal speciﬁcity and sensitivity using
arasite-infected mouse blood, and non-infected blood
rom mouse, human, bovine, goat, horse and dog. No
ross-reactivity was observed with the non-infected blood
pecimens, while the ITS1 TD PCR allowed detection and
ifferentiation of the trypanosome taxa by amplicon length
olymorphism. Indeed, the assay generated amplicons of
he expected sizes: 612 bp with T. congolense Savannah
ype, 165 bp with T. vivax and 391–393 bp with the Try-
anozoon subgenus, including T. b. brucei,  T. b. gambiense,
. b. rhodesiense, T. evansi,  and T. equiperdum. The non-
athogenic T. theileri could be discriminated by a PCR
mplicon of approximately 300 bp (Fig. 1). To assess the
ower detection limit according to the trypanosome taxon,
0-fold serial dilutions of live parasites in 1 ml  aliquots of
aïve human blood were used. At 200 l blood per sample,
TS1 TD PCR achieved an analytical sensitivity of 10 para-
ites/ml blood or 0.2 parasite equivalent/reaction with T.
ongolense (Fig. 2), T. brucei and T. evansi (data not shown).
he analytical sensitivity of ITS1 TD PCR for T. vivax was
00 parasites/ml blood or 2 parasite equivalent/reaction
Fig. 3).parasites per ml  blood and 5 parasite per ml  blood, respectively; naïve:
non-infected blood; NC: no-template negative control. M:  100-bp incre-
mental markers. Each reaction contained the equivalent of 20 L of blood.
3.2. Performance of ITS1 TD PCR on clinical specimens
A total of 246 blood specimens from 57 cattle were
examined with ITS1 TD PCR and HCT and results were
interpreted with reference to their infection status with
T. congolense Savannah or Kiliﬁ type. Specimens that were
negative in ITS1 TD PCR were veriﬁed with the vertebrate
cytochrome b PCR and were all positive (data not shown).
Firstly, speciﬁcity and sensitivity of ITS1 TD PCR were
evaluated on a collection of 114 reference specimens (69
non-infected and 45 infected specimens) from 57 cattle of1: 105 parasites per ml blood, 104 parasites per ml blood, 103 parasites
per ml blood, 102 parasites per ml blood, 10 parasites per ml  blood and
1  parasite per ml  blood, respectively; naïve: non-infected blood, NC: no-
template negative control. M:  100 bp incremental markers. Each reaction
contained the equivalent of 20 L of blood.
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Table 1
HCT and ITS1 TD PCR results obtained post treatment in the cattle of group A. The animals were treated on day 0. − denotes negative test result, + denotes
positive test result.
Days post treatment Animal identiﬁcation
CVB 197 CVB 192 CVB 190 CVB 214 CVB 193 CVB 191
HCT PCR HCT PCR HCT PCR HCT PCR HCT PCR HCT PCR
1 − − − − + − − − − + − −
2  − − − − − − − − − − − −
3  − − − − − − − − − − − −
4  − − − − − − − − − − − −
5  − − − − − − − − − − − −
6  − − − − − − − − − − − −
10  − − − − − − − − − − − −
16  − − − − − − − − − − − −
23  − − − − − − − − − − − −
 
 30  − − − − −
44  − − − − −
Discordant results between HCT and ITS1 TD PCR are indicated in bold.
Secondly, ITS1 TD PCR was evaluated as a test of cure
on the collection of 132 post-treatment specimens in 12
cattle (groups A and B) that were treated and followed
up. Four out of six animals in group A became negative
within 1 day post treatment with both ITS1 TD PCR and
HCT (Table 1). After 1 day of treatment, one animal was
positive in ITS1 TD PCR and negative in HCT, and another
animal was positive in HCT and negative in ITS1 TD PCR.
From 2 days post-treatment till the end of the sampling
period (44 days after ﬁrst treatment), all animals were neg-
ative in both the ITS1 TD PCR and the HCT. In group B, all six
animals were occasionally positive in ITS1 TD PCR and/or
HCT during the follow-up period between 1 and 16 days
after treatment and even after retreatment (on day 19) up
to day 44 after treatment (Table 2). The parasite detection
rate of ITS1 TD PCR after two treatments in animal group B
was higher than that of HCT. Positivity rate of ITS1 TD PCR
was 84.85% (56/66), while HCT was 57.58% (38/66). The
ITS1 TD PCR could detect relapse up to three days earlier
than microscopical parasite detection.4. Discussion
Livestock production is considered the main lifeline
for millions of families in many sub-Saharan countries.
Table 2
HCT and ITS1 TD PCR results obtained post treatment in the cattle of group B. T
trypanocide was  given at day 19 after the ﬁrst treatment. − denotes negative test
Day post treatment Animal identiﬁcation
CVB 198 CVB 200 CVB 199 
HCT PCR HCT PCR HCT 
1 - + + + + 
2  − − + + − 
3  − − − + − 
4  − + + + − 
5  − + + + + 
6  + + + + + 
10  + + + + + 
16  + + + + + 
23  − − − − − 
30  + + + + − 
44  + + + + + 
Discordant results between HCT and ITS1 TD PCR are indicated in bold.− − − − − − −
− − − − − − −
However, the emergence of drug resistant trypanosomes
presents a serious threat to agriculture in the regions.
Therefore, studies on drug resistance and development of
novel compounds against trypanosomes are necessary for
effective control. These studies greatly beneﬁt from rapid
and cost-efﬁcient molecular tools to detect the presence
of trypanosomes. Compared to microscopy, PCR-based
assays have the advantage that they are more amenable
to high throughput processing and that specimens can be
stored longer term. In addition, differentiation between
trypanosome taxa by microscopy is much more cumber-
some than with molecular methods, such as PCR. This
study presents an improved ITS1-based PCR assay for diag-
nosis of trypanosomosis and for efﬁcacy assessment of
trypanocidal compounds where the detection of genomic
rDNA of Trypanosoma speciﬁc ITS1 serves as surrogate for
parasite detection but with higher analytical sensitivity.
The same primer sequences were employed in a previous
survey on AAT in Ethiopia (Fikru et al., 2012). However,
the reaction mixture and cycling conditions of the ITS1
TD PCR are reﬁned for optimal sensitivity and speciﬁcity.
The “Touchdown” approach that employs more stringent
primer-template hybridisation conditions is introduced to
minimise potential non-speciﬁc ampliﬁcations. It favours
ampliﬁcation of desirable products during early cycles that
he animals were treated on day 0 and rescue treatment with a second
 result, + denotes positive test result.
CVB 204 CVB 205 CVB 202
PCR HCT PCR HCT PCR HCT PCR
+ − − − + − +
+ + − − + − −
+ − − − + − +
+ − + − − − +
+ − + + + − +
+ − + + + + +
+ + + + + + +
+ + + + + + +
− − + + + + +
+ + + + + + +
+ + + + + + +
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ill out-compete potential non-speciﬁc products during
he remaining cycles (Korbie and Mattick, 2008).
For T. congolense,  the newly developed ITS1 TD PCR has
 lower detection limit of 10 parasites/ml blood while for
. vivax, this is 100 parasites/ml blood. A similar differ-
nce in detection limits between T. congolense and T. vivax
as been observed in other PCRs such as the original ITS1
CR and a real-time PCR targeting the 18S rDNA sequence
unpublished results) and might be due to a lower copy
umber of target sequences in the T. vivax genome com-
ared to T. congolense.  Currently, the 18S based PCR-RFLP
s the FAO recommended test for detection and differentia-
ion of multiple trypanosome taxa (Geysen et al., 2003). The
8S PCR-RFLP requires one or two ampliﬁcation steps and
 restriction digestion step. On the other hand, the ITS1 TD
CR needs a single ampliﬁcation step and achieves a com-
arable detection limit, is thus less-time consuming and
ore cost-effective for detection of T. congolense,  T. vivax
nd the three species within the Trypanozoon subgenus T.
rucei,  T. evansi and T. equiperdum.
The data obtained with the blood specimens of exper-
mentally infected cattle demonstrated that ITS1 TD PCR
ad comparable performance to microscopy in revealing
he absence or presence of a T. congolense infection prior
o treatment. After curative treatment, the ITS1 TD PCR
ecame negative in all animals within no more than two
ays, thus proving the rapid clearance of DNA from dead
arasites in the blood. The discordant result at day 1
ost-treatment in animal CVB 190, with positive HCT and
egative ITS1 TD PCR was conﬁrmed with a negative result
n the 18S-based real-time PCR developed in our laboratory
unpublished), but cannot be explained. In the animals that
elapsed after treatment, ITS1 TD PCR achieved a higher
ositivity rate and was able to detect recrudescence of
arasitaemia several days earlier than HCT. Therefore, ITS1
D PCR can be considered more reliable than microscopy in
ssessment of trypanocide efﬁcacy and bears the potential
o allow shortening of the post-treatment follow-up that is
urrently recommended to be 100 days.
In summary, the ITS1 TD PCR offers an alternative tool
or trypanosome diagnosis and assessment of compound
fﬁcacy against T. congolense in cattle. The ability to detect
nd differentiate multiple Trypanosoma taxa in a single
un, with the potential to identify mixed infections, indi-
ates the application of the ITS1 TD PCR for research on
ther pathogenic trypanosomes, such as T. vivax, T. evansi,
. equiperdum and T. brucei.
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